Advances in Therapy · 2023 · 14 citations · 39 references
PharmacyPharmacotherapyHealth AssessmentOccupational HealthPulmonary Function TestingAsthma ManagementHealth-related Quality Of Life MeasurementRespiratory HealthAdherenceAsthma Maintenance TherapyAsthma Quality Of LifeAsthma Severity AssessmentLong-acting Beta AgonistsProductivityQualitative InterviewingQuantitative Data Collection
INTRODUCTION: There is limited information regarding multidimensional relationships between asthma control and health-related quality of life (HRQoL), work productivity, and asthma symptom burden in Japan. Furthermore, systematic qualitative investigations about asthma burden have not been performed. METHODS: -agonists (ICS/LABA). The primary endpoint was impact of asthma on HRQoL, measured using the Asthma Health Questionnaire-33 (AHQ-33). Secondary endpoints were cough burden (Japanese-adapted Leicester Cough Questionnaire [J-LCQ]) and impact of asthma on work/activities (asthma-specific Work Productivity and Activity Impairment Questionnaire [WPAI:Asthma]). Quantitative data were assessed for the overall population and for well-controlled (WC) and not well-controlled (NWC) asthma subgroups. Qualitative verbal interviews further assessed the impact of NWC asthma on patients' HRQoL; emergent themes were extracted using thematic analyses. RESULTS: Of 454 patients, 45.2% (n = 205) had NWC asthma. Patients with NWC asthma had significantly worse asthma- and cough-related HRQoL across all AHQ-33 and J-LCQ domains and significantly greater work and activity impairment versus patients with WC asthma, across all assessed WPAI:Asthma domains. AHQ-33 total score was highly correlated with J-LCQ total and domain scores (r = - 0.8132 to r = - 0.7407). Nine themes emerged from qualitative interviews and confirmed that patients with NWC asthma had considerable HRQoL impairment due to asthma symptoms. CONCLUSIONS: Patients with NWC asthma had higher symptom burden and worse HRQoL than patients with WC asthma, despite ICS/LABA adherence. Cough burden correlated with HRQoL, suggesting cough may be one of the key markers to inform treatment strategy for patients with asthma.
39
Theo Vos, Stephen S Lim, Cristiana Abbafati et al. · The Lancet · 2020 · 19.2K citations · Full text
Saturation in qualitative research: exploring its conceptualization and operationalization
Benjamin Saunders, Julius Sim, Tom Kingstone et al. · Quality & Quantity · 2017 · 11.6K citations · Full text
Development of the asthma control test
Robert A. Nathan, Christine A. Sorkness, Mark Kosinski et al. · Journal of Allergy and Clinical Immunology · 2004 · 2.9K citations